Lv1
28 积分 2024-01-23 加入
Neoantigen-specific mRNA/DC vaccines for effective anticancer immunotherapy
3天前
已完结
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
1个月前
已完结
The efficacy and safety of glucagon-like peptide-1 receptor agonists in non-diabetic adults with overweight/obesity: An umbrella review of systematic reviews and meta-analyses
1个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
2个月前
已完结
降糖减重药物对肌肉减少的影响
2个月前
已完结
结构化电子病历设计及质量管理实践
2个月前
已完结
New Molecules and Indications for GLP-1 Medicines
3个月前
已完结
World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
3个月前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
